Holdings of ADAR1 Capital Management, LLC
249 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 43.2 % of the equity sleeve
Sector breakdown
- Health care 4.2 %
- Industrials 0.8 %
- Communication 0.1 %
- Unattributed 94.8 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
The quoted currency of each line, as declared.
Country breakdown
- US 82.3 %
- FR 14.3 %
- KY 2.3 %
- IL 0.6 %
- DK 0.5 %
- GB 0.1 %
- DE 0.1 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|
| 1 | US | 233 | 1.2B $ | 82.25 % |
| 2 | FR | 4 | 203.7M $ | 14.26 % |
| 3 | KY | 5 | 32.6M $ | 2.28 % |
| 4 | IL | 1 | 8.1M $ | 0.57 % |
| 5 | DK | 2 | 6.9M $ | 0.49 % |
| 6 | GB | 3 | 1.3M $ | 0.09 % |
| 7 | DE | 1 | 888.8K $ | 0.06 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|
| 201 | Rubrik Inc | 4,900 | 240K $ | |
| 202 | Surgery Partners Inc | 20,000 | 238.4K $ | |
| 203 | Larimar Therapeutics Inc | 52,745 | 237.4K $ | |
| 204 | Evolus Inc | 55,859 | 229.6K $ | |
| 205 | Q32 Bio Inc | 35,000 | 224.7K $ | |
| 206 | LONGEVERON INC | 200,000 | 208K $ | |
| 207 | AnaptysBio Inc | 3,698 | 205.1K $ | |
| 208 | KalVista Pharmaceuticals Inc | 10,000 | 201.3K $ | |
| 209 | Kyverna Therapeutics Inc | 22,428 | 193.6K $ | |
| 210 | Nuvation Bio Inc | 43,500 | 186.6K $ | |
| 211 | Benitec Biopharma Inc | 17,500 | 186.4K $ | |
| 212 | Lipocine Inc | 23,180 | 185.2K $ | |
| 213 | RALLYBIO CORP | 20,535 | 184.2K $ | |
| 214 | Rezolute Inc | 58,679 | 179K $ | |
| 215 | Q/C Technologies Inc | 50,000 | 172.5K $ | |
| 216 | Erasca Inc | 10,000 | 161.8K $ | |
| 217 | Coya Therapeutics Inc | 40,900 | 161.1K $ | |
| 218 | Personalis Inc | 25,000 | 159.3K $ | |
| 219 | SI-BONE Inc | 12,580 | 158.9K $ | |
| 220 | Oncology Institute Inc/The | 50,000 | 153.5K $ | |
| 221 | Neuronetics Inc | 100,000 | 145K $ | |
| 222 | Ardelyx Inc | 23,900 | 143.2K $ | |
| 223 | ACHIEVE LIFE SCIENCES INC | 47,800 | 140.5K $ | |
| 224 | Voyager Therapeutics Inc | 35,000 | 135.1K $ | |
| 225 | JASPER THERAPEUTICS INC | 140,000 | 122.7K $ | |
| 226 | NEUPHORIA THERAPEUTICS INC | 30,000 | 122.1K $ | |
| 227 | Arcturus Therapeutics Holdings Inc | 15,000 | 115.8K $ | |
| 228 | MacroGenics Inc | 40,000 | 115.6K $ | |
| 229 | C4 Therapeutics Inc | 43,000 | 113.1K $ | |
| 230 | Recursion Pharmaceuticals Inc | 35,000 | 107.5K $ | |
| 231 | Design Therapeutics Inc | 10,000 | 106.4K $ | |
| 232 | Gossamer Bio Inc | 287,531 | 94.5K $ | |
| 233 | Immix Biopharma Inc | 10,000 | 91.1K $ | |
| 234 | LITE STRATEGY INC | 67,292 | 78.1K $ | |
| 235 | VERU INC | 35,000 | 77.4K $ | |
| 236 | Kyntra Bio Inc | 10,469 | 71K $ | |
| 237 | Clover Health Investments Corp | 40,000 | 70.4K $ | |
| 238 | BIOMEA FUSION INC | 43,420 | 66.4K $ | |
| 239 | Neumora Therapeutics Inc | 33,100 | 64.5K $ | |
| 240 | Organon & Co | 10,000 | 59.9K $ | |
| 241 | Esperion Therapeutics Inc | 21,400 | 58.6K $ | |
| 242 | MEREO BIOPHARMA GROUP PLC | 150,000 | 49.5K $ | |
| 243 | AN2 Therapeutics Inc | 13,861 | 47.4K $ | |
| 244 | Aquestive Therapeutics Inc | 10,000 | 41.5K $ | |
| 245 | aTyr Pharma Inc | 50,685 | 39.5K $ | |
| 246 | BIOATLA INC | 228,107 | 36.7K $ | |
| 247 | KALA BIO INC | 141,480 | 24.5K $ | |
| 248 | Coherus Oncology Inc | 10,366 | 17.5K $ | |
| 249 | QUINCE THERAPEUTICS INC | 50,100 | 5.1K $ | |